Both in Pharmaceuticals
TuHURA Biosciences vs AN2 Therapeutics
Over the past year HURA returned −9.7% and ANTX returned +197.5%; their daily moves had a correlation of 0.06.
HURA −9.7% ANTX +197.5%Growth of $1, one year, split-adjusted
| Metric | HURA | ANTX |
|---|---|---|
| Price | $2.09 | $3.60 |
| Market cap | $132.9M | $135.9M |
| Today | +18.47% | +1.12% |
| 1 month | −2.1% | −25.5% |
| 6 months | −22.2% | −10.0% |
| Year to date | +175.5% | +215.8% |
| 1 year | −14.9% | +195.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | -$4.2M | $78.4M |
| Dividend yield | — | — |
| Volatility (60d) | 67.0% | 69.6% |
| Short % of float | 13.7% | 8.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).